StreetInsider.com News Articles

Form 8-K Pelthos Therapeutics For: May 28

Thu, 28 May 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260528/26568705.html

Form 8-K Pelthos Therapeutics For: May 28

Thu, 28 May 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260528/26568705.html

Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference

Thu, 28 May 2026 17:00:00 -0400

DURHAM, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs, (“Pelthos”), today announced that CEO Scott Plesha will present at 11:05 am ET and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference on June 4, 2026 in New York. Investors interested in arranging one-on-one meetings should contact their Jefferies representative.

About Pelthos Therapeutics

Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products

Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference

Thu, 28 May 2026 17:00:00 -0400

About Pelthos Therapeutics

Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products

Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference

Thu, 28 May 2026 17:00:00 -0400

About Pelthos Therapeutics

Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products

Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference

Thu, 28 May 2026 17:00:00 -0400

About Pelthos Therapeutics

Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products

Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference

Thu, 28 May 2026 17:00:00 -0400

About Pelthos Therapeutics

Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products

Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference

Thu, 28 May 2026 17:00:00 -0400

About Pelthos Therapeutics

Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products

Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference

Thu, 28 May 2026 17:00:00 -0400

About Pelthos Therapeutics

Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products

Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference

Thu, 28 May 2026 17:00:00 -0400

About Pelthos Therapeutics

Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products

Form 4 Pelthos Therapeutics For: May 22 Filed by: Francis Knuettel II

Tue, 26 May 2026 19:17:00 -0400

si-local-file:///var/storage/secattach/20260526/26551846.html

Form 4 Pelthos Therapeutics For: May 22 Filed by: Francis Knuettel II

Tue, 26 May 2026 19:17:00 -0400

si-local-file:///var/storage/secattach/20260526/26551846.html

Form 144 Pelthos Therapeutics Filed by: Francis Knuettel II

Fri, 22 May 2026 12:46:00 -0400

si-local-file:///var/storage/secattach/20260522/26540328.html

Form 144 Pelthos Therapeutics Filed by: Francis Knuettel II

Fri, 22 May 2026 12:46:00 -0400

si-local-file:///var/storage/secattach/20260522/26540328.html

Form 8-K Pelthos Therapeutics For: May 15

Thu, 21 May 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260521/26536504.html

Form 8-K Pelthos Therapeutics For: May 15

Thu, 21 May 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260521/26536504.html

Form 4 Pelthos Therapeutics For: May 14 Filed by: Friedberg Ezra M

Mon, 18 May 2026 18:11:00 -0400

si-local-file:///var/storage/secattach/20260518/26515455.html

Form 4 Pelthos Therapeutics For: May 14 Filed by: Friedberg Ezra M

Mon, 18 May 2026 18:11:00 -0400

si-local-file:///var/storage/secattach/20260518/26515455.html

Form SCHEDULE 13G/A Pelthos Therapeutics Filed by: Ikarian Capital, LLC

Fri, 15 May 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260515/26507508.html

Form SCHEDULE 13G/A Pelthos Therapeutics Filed by: Ikarian Capital, LLC

Fri, 15 May 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260515/26507508.html

Pelthos Therapeutics (PTHS) PT Raised to $66 at Oppenheimer

Thu, 14 May 2026 16:11:17 -0400

Oppenheimer analyst Jeff Jones raised the price target on Pelthos Therapeutics (NYSE: PTHS) to $66.00 (from $62.00) while maintaining a Outperform rating.

Pelthos Therapeutics Inc. (PTHS) Misses Q1 EPS by 258c

Thu, 14 May 2026 07:12:37 -0400

Pelthos Therapeutics Inc. (NYSE: PTHS) reported Q1 EPS of ($3.09), $2.58 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $10.91 million.

For earnings history and earnings-related data on Pelthos Therapeutics Inc. (PTHS) click here.

Form 8-K Pelthos Therapeutics For: May 14

Thu, 14 May 2026 07:08:00 -0400

si-local-file:///var/storage/secattach/20260514/26489793.html

Form 8-K Pelthos Therapeutics For: May 14

Thu, 14 May 2026 07:08:00 -0400

si-local-file:///var/storage/secattach/20260514/26489793.html

Form 10-Q Pelthos Therapeutics For: Mar 31

Thu, 14 May 2026 07:07:00 -0400

si-local-file:///var/storage/secattach/20260514/26489790.html